Colon cancer: preventive agents and the present status of chemoprevention

@article{Half2009ColonCP,
  title={Colon cancer: preventive agents and the present status of chemoprevention},
  author={Elizabeth E. Half and Nadir Arber},
  journal={Expert Opinion on Pharmacotherapy},
  year={2009},
  volume={10},
  pages={211 - 219}
}
Background: Colorectal cancer (CRC) is one of the most common cancers worldwide and a prevalent cause of morbidity and mortality. CRC has a natural history of transition from a precursor lesion, ie adenomatous polyp to cancer, that spans over 10 to 15 years providing an extended opportunity for intervention and cancer prevention. Suppression of the carcinogenic process by use of pharmacological or natural agents is the cornerstone of chemoprevention. Objectives: The aim of this review was to… Expand
Anti-inflammatory agents as cancer therapeutics.
  • K. Kashfi
  • Medicine
  • Advances in pharmacology
  • 2009
TLDR
This chapter reviews a host of naturally occurring compounds/micronutrients that have chemopreventive properties, their utility and mechanism(s) of action against the background of mediators that link inflammation and cancer. Expand
Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines.
TLDR
From the data reviewed in this article, it can be concluded that these compounds inhibit cell growth, by inducing cell cycle arrest and/ or apoptosis; inhibit proliferation, angiogenesis, and/or metastasis; and exhibit anti-inflammatory and-or antioxidant effects. Expand
Nrf 2 as a Chemopreventive Target in Colorectal Cancer
Introduction—Numerous epidemiological studies have linked consumption of cruciferous vegetables to a reduced risk of colorectal cancer (CRC) in individuals. It is currently well accepted that chronicExpand
Colorectal cancer chemoprevention: the potential of a selective approach
TLDR
This study demonstrates that induction of TRAIL-mediated death signaling contributes to the chemopreventive value of all-trans-retinyl acetate (RAc) by sensitizing premalignant adenoma cells for apoptosis without affecting normal cells. Expand
Overview of gastrointestinal cancer prevention in Asia.
TLDR
Whereas in Western countries cancer chemotherapeutics involve strategies not only to block the growth of the primary tumor, but also to inhibit its progression to metastatic disease, the endless pursuit of effective agents for cancer prevention may be a unique and featured strategy in Asia. Expand
Colorectal cancer in women: hormone replacement therapy and chemoprevention
  • E. Barnes, M. D. Long
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2012
TLDR
Data on CRC pathogenesis and risk in women, and the requirements for implementation of chemopreventive agents, are summarized and why HRT should not be used for this indication given current knowledge are discussed. Expand
Chemoprevention of familial adenomatous polyposis
Familial adenomatous polyposis (FAP) has always been first and foremost a surgical disease, whose treatment with colectomy has long been known to reduce risk of premature cancer death. The notion ofExpand
Bioactive Natural Products From the Genus Kalanchoe as Cancer Chemopreventive Agents: A Review
TLDR
The use of some species belonging to genus Kalanchoe could be of interest for the development of chemopreventive studies, thanks to their capacity to biosynthesize several bioactive compounds with cytotoxic and other anticancer-associated properties. Expand
Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
TLDR
Results show for the first time the efficacy and associated mechanisms of long-term p.o. silibinin feeding against spontaneous intestinal tumorigenesis in the APC(min/+) mice model, suggesting its chemopreventive potential against intestinal cancers including CRC. Expand
Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol.
TLDR
Observations reveal that RVT inhibits colon tumorigenesis when given together with BaP and holds promise as a therapeutic agent. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 106 REFERENCES
Chemoprevention of colorectal neoplasia: the potential for personalized medicine.
TLDR
These landmark studies are very important, as they provide a proof of concept that the authors can prevent high risk adenomas that can lead to CRC development, and the ideal chemopreventive agent remains to be discovered. Expand
Colon cancer prevention by NSAIDs: what is the mechanism of action?
  • D. Ahnen
  • Medicine
  • The European journal of surgery. Supplement. : = Acta chirurgica. Supplement
  • 1998
TLDR
The entire class of NSAIDs appear to be effective in preventing carcinogen induced colon cancer in animal models, and clinical trials using the NSAID sulindac have shown dramatic regression of colonic adenomas in patients with Familial Polyposis. Expand
Do NSAIDs prevent colorectal cancer?
  • N. Arber
  • Medicine
  • Canadian journal of gastroenterology = Journal canadien de gastroenterologie
  • 2000
TLDR
There is increasing evidence to suggest that acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colorectal cancer and a need to establish the dose, duration and frequency of use required for cancer-preventive activity. Expand
Chemoprevention of colorectal cancer.
  • J. Faivre, C. Bonithon-Kopp
  • Medicine
  • Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 1999
TLDR
Most of the available data do not support the idea of a protective effect of vitamins and antioxidants against colorectal carcinogenesis, so it is too early to draw any conclusions on the effects of fibre, calcium supplementation, aspirin therapy and dietary intervention. Expand
NSAIDs and chemoprevention.
TLDR
Unresolved questions with regard to safety, efficacy, optimal treatment regimen, and mechanism of action currently limit the clinical application of NSAIDs to the prevention of polyposis in FAP patients, and there is growing optimism for the view that full exploration of the role ofNSAIDs in the prevention and treatment of epithelial cancers will serve towards reducing of mortality and morbidity from various cancers. Expand
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
TLDR
Results indicate that dietary sulindac at 160 and 320 ppm levels inhibited the incidence of invasive and noninvasive adenocarcinomas of the colon and suppressed the colon tumor volume in a dose-dependent manner. Expand
Drugs to prevent colon cancer show promise, but hurdles remain for chemoprevention.
  • R. Tuma
  • Biology, Medicine
  • Journal of the National Cancer Institute
  • 2008
TLDR
The APC data show that the use of nonsteroidal antiinfl ammatory drugs, specifi cally a cyclooxygenase-2 (COX-2) inhibitor, reduces the development of adenomas instead of just masking the presence of lesions. Expand
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
TLDR
Evidence is provided, for the first time, that a specific COX-2 inhibitor, celecoxib, possesses strong chemopreventive activity against colon carcinogenesis. Expand
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis
TLDR
A decision analytic model was constructed to explore the incremental clinical and economic effects of aspirin when it is added to an accepted screening program for sporadic colorectal cancer and the potential role of aspirin chemoprevention in an unscreened population and the effects of screening when added to existing aspirin use. Expand
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
TLDR
The high complication cost and the lower efficacy of aspirin render screening colonoscopy a more cost-effective strategy to prevent colorectal cancer. Expand
...
1
2
3
4
5
...